Spruce Biosciences SPRB
NASDAQ SPRB
$42.73 +1.50 (+3.64%)
At close: Oct 21, 2026 · 4:00 PM EDT

Spruce Biosciences (SPRB) Preferred Stock Liabilities (2019 - 2020)

Updated

Spruce Biosciences' Preferred Stock Liabilities came in at $115.45 million for Q3 2020, up 315.1% from $27.81 million a year earlier and up 61.6% from the prior quarter.

Analysis

Spruce Biosciences (SPRB) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

At the end of FY2019, Spruce Biosciences' Preferred Stock Liabilities was $27.81 million.

  • Business Quant data shows SPRB's Preferred Stock Liabilities at $71.46 million (Q2 2020), $71.46 million (Q1 2020) and $27.81 million (Q4 2019) in the three quarters before Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Spruce Biosciences 103.09 Mn -106.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 115.45 Mn
Jun 30, 2020 71.46 Mn
Mar 31, 2020 71.46 Mn
Dec 31, 2019 27.81 Mn
Sep 30, 2019 27.81 Mn
API Access

Spruce Biosciences Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=SPRB&period=max&api_key=YOUR_API_KEY